Amid wave of IPOs, IPOX 100 U.S. Index (ETF: FPX) on course to close Thursday at Highest Level on Record
IPOX Schuster LLC, the innovative Financial Services Firm behind the IPOX Indexes Strategies, is pleased to note a fresh All-Time High in its IPOX 100 U.S. Index (IPXO).
As of 13:15 pm ET, June 13, 2019, the IPOX 100 U.S. (IPXO) added +0.48% to +24.97% YTD.
The FANG-free, diversified USD trillion 1.7 IPOX 100 U.S. Index (IPXO) captures the performance of 100 of the largest and best U.S. IPOs, Spin-offs and IPO M&A by applying the IPOX® Indexes Technology. Positions currently include a Satellite Portfolio consisting of a large number of IPOs in the small- and mid-cap space centered around a Core Portfolio composed of some of the largest and most liquid Spin-offs and IPO M&As over the past years.
Today’s further move into uncharted territory was driven by big gains in growth firms insulated from trade tensions and fears about more regulatory scrutiny including biotech Regenxbio (RGNX US: +6.08%), high-end camping products maker Yeti (YETI US: +4.94%) or application software maker Anaplan (PLAN US: +4.10%).
The IPOX 100 U.S. (IPXO) serves as underlying for a number of Financial Products, including the First Trust IPOX® U.S. Equity Opportunities ETF (ticker: FPX).
Incepted on 04/13/2006, the 5-star (10 year) USD billion 1.2 “FPX” ETF has produced a Total Return of +330.20% vs. 193.31% for the ETF tracking the S&P 500 (SPY) since launch, an annual difference of +320 bps. in favor of the “FPX” ETF after fees. The “FPX” ETF currently trades at a Beta of 1.08. (Source: Bloomberg)
For further information, please contact us using the co-ordinates below.
The IPOX Team
IPOX Schuster LLC
Josef Schuster, PM
225 West Washington, Suite 400
Chicago, IL 60606
(312) 827-3681 (office)
(312) 339-4114 (cell)